Related content

A phase I study of combination therapy with S-1 and irinotecan (CPT-11) in patients with advanced colorectal cancer

By Shiozawa Manabu   Sugano Nobuhiro   Tsuchida Kazuhito   Morinaga Soichiro   Akaike Makoto   Sugimasa Yukio  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 3, 2009-03 ,pp. : 365-370

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer

By Komatsu Yoshito   Yuki Satoshi   Sogabe Susumu   Fukushima Hiraku   Nakatsumi Hiroshi   Kobayashi Yoshimitsu   Iwanaga Ichiro   Nakamura Michio   Hatanaka Kazuteru   Miyagishima Takuto   Kudo Mineo   Munakata Masaki   Meguro Takashi   Tateyama Miki   Sakata Yuh  

Acta Oncologica, Vol. 51, Iss. 7, 2012-09 ,pp. : 867-872

Informa Healthcare

Access to resources Recommend Favorite

Health-related quality of life in patients with advanced colorectal cancer: results from a phase II study of S-1 combined with irinotecan (CPT-11)

By Tsunoda Akira   Yasuda Naokuni   Nakao Kentaro   Narita Kazuhiro   Watanabe Makoto   Matsui Nobuaki   Tsunoda Yuko   Kusano Mitsuo  

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 280-286

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancer

By Kusaba Hitoshi   Esaki Taito   Kishimoto Junji   Uchino Keita   Arita Shuji   Kumagai Hozumi   Mitsugi Kenji   Akashi Koichi   Baba Eishi  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 29-34

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II study of irinotecan, 5-fluorouracil, and l-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer

By Goto Ayumu   Yamada Yasuhide   Hosokawa Ayumu   Ura Takashi   Arai Tatsuhiro   Hamaguchi Tetsuya   Muro Kei   Shimada Yasuhiro   Shirao Kuniaki  

International Journal of Clinical Oncology, Vol. 9, Iss. 5, 2004-10 ,pp. : 364-368

Springer Publishing Company

Access to resources Recommend Favorite